Regulation on Outbound Investment: Why Chinese Counterparty Compliance Is Now a Deal Risk

On June 1, 2026, China’s State Council promulgated the Regulation on Outbound Investment (《国务院关于对外投资的规定》), effective July 1. The Regulation provides the clearest legal basis yet for Chinese authorities to review and potentially prohibit cross-border transactions that could result in the transfer of critical technology, data, or strategic assets beyond Chinese jurisdiction, selecting three categories of activity that will now be expressly regulated.

These categories of activity are (1) offshore restructurings (what some practitioners describe as a “Singapore Wash”), (2) technology transfers through licensing or personnel deployment—even without an equity component—and (3) disposals of existing overseas assets.

Where the Chinese party has not obtained the required clearance, Chinese authorities may continue to assert regulatory authority over the underlying transaction and assets regardless of where the holding entity is incorporated, with penalties including forfeiture of gains, fines of up to 10‰ of investment value, activity bans, and personal liability for responsible managers.

For deal practitioners, the immediate implication is a diligence obligation: any asset with Chinese origins must now be assessed on whether it has been properly cleared under the Regulation, and, if not, whether Chinese authorities may assert regulatory authority over those assets. If the asset is captured and falls within a sensitive sector, the transaction may not be clearable—the Regulation’s purpose is to give authorities the legal basis to prohibit transfers they consider harmful to national security, not merely create a process.

Acquirers must also consider the bilateral dimension: the same transaction may simultaneously be subject to outbound investment restrictions in the acquirer’s own jurisdiction (for example, the US COINS Act), creating a narrowing corridor for cross-border transactions in sensitive sectors.

WHAT THE REGULATION NOW COVERS

The closest US analogue is the COINS Act (outbound investment screening for AI, advanced semiconductors and microelectronics, quantum, supercomputing, and hypersonic systems), but the policy logic is distinct. The US framework is offensive: designed to deny adversaries access to capital and expertise in specified sectors.

China’s Regulation is fundamentally defensive: its concern is whether an investment structure results in loss of Chinese control over critical technology and data. This explains the breadth of transaction types captured—the trigger is not a sector list but the functional question of whether assets “seep beyond” Chinese jurisdiction.

The Regulation captures three categories of cross-border activity that previously lacked an express State Council–level statutory basis:

1. Offshore Restructuring (a ‘Singapore Wash’)
   
   A Chinese company or its founders contribute core technology, IP, or data to an offshore holding entity, flipping assets to a Cayman or Singapore vehicle so that a subsequent acquisition appears purely offshore. Under Article 2, this restructuring step itself constitutes outbound investment (which now explicitly includes individual investors). If the assets may affect national security, the transaction is subject to Article 15 security review.


2. Technology Transfer Through Licensing or Personnel Deployment
   
   A Chinese company licenses proprietary technology to a foreign partner and dispatches engineers to establish or operate an overseas facility. Article 13 identifies three standalone channels through which controlled technology may be transferred: direct export, transfer through personnel deployment, and cross-border data transfer.
   
   These obligations are triggered independently, so no equity component is required. A pure licensing arrangement with dispatched engineers is captured if the technology or know-how falls within restricted categories. Where the arrangement also includes an equity component (for example, the Chinese company takes a stake in the overseas facility or contributes IP to a joint venture), the transaction additionally enters ODI scope and may trigger Article 15 security review.


3. Disposal of Overseas Assets
   
   A Chinese company sells its existing overseas subsidiary or offshore asset portfolio to a foreign acquirer. Article 15 expressly covers “dispositions” (处分) of overseas assets and interests. Exit transactions—not just entry transactions—are now within the security review perimeter if they may affect national security.

Common Deal Risk Across All Three Scenarios

The consequence of noncompliance is the same regardless of transaction type. Where the Chinese party has not obtained the required clearance, Chinese authorities may continue to assert regulatory authority over the underlying assets and can impose significant administrative consequences (as detailed below).

From the acquirer’s perspective, this raises a threshold characterization question: is the acquirer investing in a genuinely independent offshore entity, or one whose core assets remain subject to Chinese government jurisdiction? If the latter, the counterparty’s compliance gap becomes the acquirer’s deal risk.

WHAT THE REGULATION DOES NOT COVER

Pure commercial licensing or royalty arrangements that do not involve equity participation, capital contribution, or the acquisition of control rights generally fall outside “outbound investment” under Article 2 and therefore outside the ODI filing and Article 15 security review perimeter.

However, as discussed in Scenario 2 above, such arrangements are not necessarily outside the Regulation’s reach entirely: Article 13’s export control obligations apply independently where the licensing involves restricted technology, personnel deployment, or cross-border data transfer. The distinction is between ODI scope (which requires an investment element) and export control scope (which does not).

The Regulation does not apply to purely inbound transactions. A foreign company acquiring a Chinese domestic entity is governed by separate foreign investment and national security review frameworks.

PENALTIES AND PERSONAL LIABILITY (ARTICLES 27–30)

• For prohibited investments: Forfeiture of illegal gains, orders to cease activities and dispose of shares/assets, and fines of 5‰ to 10‰ of total investment value
• For security review violations (Article 28): Forfeiture of gains, fines, mandatory remediation, 1-to-3-year bans on all outbound investment activity, and orders to dispose of existing investments

Personal liability attaches to directly responsible managers and other directly responsible personnel (fines of RMB 50,000 to 100,000), which could include directors, finance, legal, or compliance personnel depending on their role in the violation.

WHAT THIS MEANS FOR THE TRANSACTION

The penalties described above fall on the Chinese investor. But for an offshore acquirer, the more immediate concern is what happens to the transaction itself—and to the asset post-closing—if the underlying transfer out of China was never properly cleared.

First, there is a title and ownership risk. If Chinese authorities determine that the original outbound transfer was noncompliant, they may order remediation, which may include, in the most serious cases, unwinding the transfer or requiring disposal of the offshore asset. An acquirer that has already closed may find that the asset it purchased is subject to a regulatory claim that did not appear in the seller’s representations.

Second, there is ongoing operational risk. Where the asset involves technology or data that originated in China, Chinese authorities may assert continuing regulatory authority over its use, further development, or onward transfer, even after the asset has changed hands offshore. This can constrain the acquirer’s ability to commercialize, sublicense, or integrate the asset into its broader portfolio.

Third, there is counterparty performance risk. If the Chinese party is subject to enforcement—activity bans, forfeiture orders, or personal liability for its managers—it may be unable to perform post-closing obligations such as transition services, ongoing technical support, indemnification, or continued licensing arrangements.

Finally, there is a valuation and exit risk. A jurisdictional defect that is discoverable in diligence will be discovered by the next buyer as well. An asset with an unresolved Chinese regulatory claim is harder to refinance, harder to exit, and likely to trade at a discount—if it can be transferred at all.

PRACTICAL IMPLICATIONS

The diligence question is now front-loaded. Before committing significant time and cost to structuring, deal teams should assess: does the target asset have Chinese origins? If so, has the asset’s migration offshore been properly cleared? This is not always apparent from the face of the transaction—assets may have passed through multiple restructurings, with compliance gaps buried several layers back. The cost of discovering a jurisdictional defect post-signing is materially higher than the cost of identifying it in preliminary diligence.

Where the diligence reveals that the asset is within scope and involves a sensitive sector, the next question is not “how do we structure around it” but “is this transaction viable at all.” Deal teams should engage Chinese regulatory counsel early; not to find a workaround, but to assess whether clearance is realistically obtainable given the sector, the technology involved, and the current enforcement posture.

Finally, acquirers should map the bilateral regulatory landscape before proceeding. A transaction that is clearable under Chinese ODI rules may still be blocked by the acquirer’s home-country outbound investment regime or vice versa. The sequencing and interaction of these parallel workstreams—each with different timelines, different triggers, and potentially conflicting policy objectives—should be assessed at the outset rather than discovered mid-execution.

We would be pleased to discuss how these considerations apply to specific transactions.

LOOKING AHEAD

The era in which cross-border transactions with Chinese counterparties could be structured purely on commercial terms, with regulatory compliance treated as a ministerial formality, has ended.

While the Regulation may not prohibit cross-border business, it will formalize the rules of engagement and raise the consequences of noncompliance to a level that makes preclosing regulatory analysis increasingly critical for any transaction involving sensitive technology, data, or strategic assets. Your Chinese counterparty’s compliance obligations are now, inescapably, your deal risk.